Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$715
|
$677B |
13.3x |
34.2x |
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$183
|
$387B |
6.7x |
14.9x |
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$153
|
$381B |
4.2x |
11.7x |
Novo Nordisk
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 446
|
$313B |
6.7x |
13.7x |
Roche
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Imaging & Diagnostics
|
CHF 261
|
$275B |
3.7x |
9.3x |
Novartis
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 93
|
$247B |
4.5x |
11.0x |
AstraZeneca
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£104
|
$242B |
4.2x |
12.2x |
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$78
|
$221B |
3.4x |
8.1x |
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$272
|
$195B |
5.7x |
10.1x |
Thermo Fisher Scientific
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Supplies
|
$400
|
$179B |
4.2x |
16.6x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$23
|
$175B |
2.8x |
7.2x |
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$107
|
$150B |
5.2x |
12.2x |
Danaher
|
United States of America |
Medical Devices,
Laboratory Services,
Medical Supplies
|
$187
|
$149B |
6.2x |
19.6x |
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€93
|
$144B |
2.8x |
9.6x |
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$47
|
$135B |
2.8x |
12.2x |
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$434
|
$107B |
9.4x |
40.6x |
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£14
|
$96.5B |
2.3x |
6.6x |
CSL
|
Australia |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
AUD 246
|
$87.2B |
5.6x |
16.8x |
Chugai Pharmaceutical
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 7516
|
$79.5B |
9.6x |
19.4x |
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$162
|
$77.1B |
8.3x |
19.3x |
Takeda Pharmaceuticals
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4148
|
$73.6B |
2.3x |
8.9x |
Merck KGaA
|
Germany |
Biopharmaceuticals,
Drug Development & Therapeutics,
Advanced Materials
|
€114
|
$64.3B |
2.7x |
9.3x |
Bayer
|
Germany |
Biopharmaceuticals,
Agriculture,
Drug Development & Therapeutics,
Health & Beauty
|
€24
|
$64.1B |
1.2x |
5.8x |
Haleon
|
United Kingdom of Great Britain and Northern Ireland |
Health & Beauty,
Drug Development & Therapeutics
|
£4
|
$60.3B |
4.0x |
15.9x |
Regeneron Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$597
|
$58.8B |
4.2x |
11.6x |
Lonza Group
|
Switzerland |
Contract Research & Manufacturing,
Biopharmaceuticals
|
CHF 561
|
$53.1B |
6.3x |
22.1x |
Samsung BioLogics
|
South Korea |
Contract Research & Manufacturing
|
KRW 1016000
|
$52.7B |
14.5x |
35.4x |
Sun Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1719
|
$46.0B |
7.4x |
26.0x |
Jiangsu Hengrui
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 56
|
$45.9B |
11.4x |
44.6x |
Daiichi Sankyo
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 3753
|
$44.3B |
3.3x |
16.5x |
IDEXX Laboratories
|
United States of America |
Medical Devices,
Laboratory Services,
Healthcare Software
|
$505
|
$41.5B |
10.4x |
30.8x |
Fresenius
|
Germany |
Hospitals & Clinics,
Medical Supplies,
Drug Development & Therapeutics
|
€43
|
$40.3B |
1.6x |
10.0x |
IQVIA
|
United States of America |
Contract Research & Manufacturing,
Health Data & Analytics,
Healthcare Software
|
$138
|
$36.5B |
2.3x |
9.8x |
Alnylam Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$289
|
$36.4B |
14.5x |
222.8x |
UCB
|
Belgium |
Vaccines & Immunotherapies
|
€160
|
$36.0B |
4.9x |
18.7x |
Teva Pharmaceuticals
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ILS 59
|
$34.4B |
2.0x |
7.0x |
Agilent
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Imaging & Diagnostics
|
$110
|
$33.2B |
5.0x |
17.1x |
argenx
|
Belgium |
Drug Development & Therapeutics
|
€516
|
$32.4B |
11.1x |
94.9x |
Galderma Group
|
Switzerland |
Health & Beauty,
Drug Development & Therapeutics
|
CHF 103
|
$31.9B |
6.6x |
28.7x |
BeiGene
|
Hong Kong |
Drug Development & Therapeutics
|
HKD 153
|
$28.5B |
6.7x |
-179.3x |
Labcorp
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$242
|
$26.4B |
2.0x |
11.7x |
Mettler Toledo
|
United States of America |
Laboratory Services,
Medical Devices
|
$1136
|
$25.6B |
6.6x |
20.6x |
Quest Diagnostics
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$170
|
$25.3B |
2.5x |
12.5x |
Celltrion
|
South Korea |
Biopharmaceuticals
|
KRW 152700
|
$25.1B |
8.9x |
29.9x |
Sartorius Stedim Biotech
|
France |
Medical Devices,
Laboratory Services,
Contract Research & Manufacturing
|
€196
|
$24.1B |
7.4x |
25.7x |
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$23.4B |
1.6x |
5.3x |
Otsuka Holdings
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
JPY 6634
|
$23.1B |
1.4x |
6.2x |
Insulet
|
United States of America |
Medical Devices,
Drug Delivery Systems
|
$321
|
$23.0B |
10.2x |
46.2x |
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$126
|
$22.5B |
2.4x |
7.0x |
Wuxi AppTec
|
China |
Contract Research & Manufacturing,
Laboratory Services
|
CNY 63
|
$22.4B |
4.0x |
10.9x |
Bausch Health
|
Canada |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Health & Beauty
|
CAD 6
|
$22.1B |
2.2x |
6.5x |
Waters
|
United States of America |
Laboratory Services,
Medical Devices
|
$348
|
$21.9B |
7.3x |
19.9x |
Astellas Pharma
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 1391
|
$21.6B |
1.6x |
8.5x |
Natera
|
United States of America |
Genomics & Personalized Medicine,
Medical Imaging & Diagnostics
|
$152
|
$20.0B |
11.0x |
-83.4x |
Divi's Laboratories
|
India |
Contract Research & Manufacturing,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 6538
|
$19.8B |
17.7x |
55.2x |
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$32
|
$19.4B |
6.8x |
7.3x |
Summit Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$26
|
$18.8B |
N/A |
-72.6x |
Zhangzhou Pientzehuang
|
China |
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
CNY 206
|
$17.2B |
11.2x |
33.8x |
Grifols
|
Spain |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€9
|
$16.9B |
2.0x |
8.2x |
Hansoh Pharma
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 26
|
$16.3B |
9.3x |
24.8x |
Biomerieux
|
France |
Laboratory Services,
Medical Imaging & Diagnostics
|
€118
|
$15.8B |
3.4x |
14.5x |
Sichuan Biokin
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 278
|
$15.4B |
25.2x |
49.6x |
Eurofins Scientific
|
France |
Laboratory Services,
Contract Research & Manufacturing
|
€56
|
$14.8B |
1.8x |
8.3x |
Recordati
|
Italy |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€52
|
$14.3B |
5.1x |
13.9x |
Illumina
|
United States of America |
Genomics & Personalized Medicine,
Laboratory Services
|
$81
|
$14.1B |
3.3x |
12.3x |
ICON plc
|
United States of America |
Contract Research & Manufacturing,
Healthcare Software,
Health Data & Analytics
|
$127
|
$13.1B |
1.6x |
7.8x |
Torrent Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 3212
|
$13.0B |
9.5x |
29.2x |
Revvity
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics,
Health Data & Analytics
|
$90
|
$12.9B |
4.6x |
14.9x |
Cipla
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1467
|
$12.6B |
3.9x |
15.1x |
Mankind Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
INR 2438
|
$12.4B |
8.5x |
33.6x |
Exact Sciences
|
United States of America |
Medical Imaging & Diagnostics,
Genomics & Personalized Medicine
|
$56
|
$12.4B |
4.3x |
33.6x |
Alteogen
|
South Korea |
Biopharmaceuticals
|
KRW 323000
|
$12.3B |
135.8x |
274.6x |
Yunnan Baiyao Group
|
China |
Biopharmaceuticals,
Health & Beauty
|
CNY 57
|
$12.2B |
2.2x |
15.5x |
Sobi
|
Sweden |
Biopharmaceuticals,
Drug Development & Therapeutics
|
SEK 300
|
$12.1B |
4.3x |
11.8x |
Insmed
|
United States of America |
Drug Development & Therapeutics
|
$66
|
$12.0B |
29.7x |
-13.2x |
Dr. Reddy's Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1223
|
$11.7B |
3.0x |
11.4x |
Wuxi Biologics
|
Hong Kong |
Contract Research & Manufacturing
|
HKD 24
|
$11.7B |
4.3x |
12.5x |
Wantai BioPharm
|
China |
Vaccines & Immunotherapies,
Pharma Diagnostics & Analytics
|
CNY 68
|
$11.5B |
N/A |
N/A |
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$119
|
$11.3B |
4.5x |
17.8x |
Innovent Biologics
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 56
|
$11.1B |
7.8x |
281.1x |
Fosun Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
CNY 22
|
$10.9B |
1.9x |
11.2x |
Exelixis
|
United States of America |
Drug Development & Therapeutics
|
$43
|
$10.8B |
4.9x |
14.6x |
Sonic Healthcare
|
Australia |
Laboratory Services,
Medical Imaging & Diagnostics
|
AUD 26
|
$10.8B |
1.8x |
9.7x |
United Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$309
|
$10.8B |
3.6x |
6.8x |
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$10.7B |
1.7x |
5.5x |
Lupin
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1968
|
$10.6B |
3.9x |
16.6x |
Biomarin Pharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$58
|
$10.5B |
3.5x |
14.4x |
Elanco
|
United States of America |
Drug Development & Therapeutics
|
$13
|
$10.2B |
2.3x |
11.5x |
Huadong Medicine
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 42
|
$10.2B |
1.7x |
13.4x |
Incyte
|
United States of America |
Drug Development & Therapeutics
|
$65
|
$10.1B |
2.3x |
18.8x |
Ascendis Pharma
|
Germany |
Drug Development & Therapeutics
|
€141
|
$10.0B |
N/A |
N/A |
Zydus Lifesciences
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 904
|
$10.0B |
3.7x |
12.3x |
Genmab
|
Denmark |
Drug Development & Therapeutics,
Biopharmaceuticals
|
DKK 1398
|
$10.0B |
2.9x |
8.5x |
Ingredion
|
United States of America |
Food & Beverages,
Plant-Based Food
|
$137
|
$9.8B |
1.3x |
7.9x |
Zhejiang NHU
|
China |
Biopharmaceuticals,
Nutraceuticals & Cosmeceuticals
|
CNY 23
|
$9.6B |
3.1x |
7.5x |
Qiagen
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$42
|
$9.6B |
4.8x |
13.0x |
Shionogi
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
JPY 2353
|
$9.6B |
3.1x |
7.7x |
Jazz Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$108
|
$9.5B |
2.3x |
6.5x |
Orion
|
Finland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€59
|
$9.4B |
5.3x |
15.9x |
Charles River
|
United States of America |
Contract Research & Manufacturing,
Laboratory Services
|
$136
|
$9.4B |
2.4x |
9.7x |